Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases
Neurodegenerative diseases affect millions of people worldwide and are characterized by the chronic and progressive deterioration of neural function. Neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease...
Main Authors: | Dorit Trudler, Swagata Ghatak, Stuart A. Lipton |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/15/8196 |
Similar Items
-
Mechanisms of hyperexcitability in Alzheimer’s disease hiPSC-derived neurons and cerebral organoids vs isogenic controls
by: Swagata Ghatak, et al.
Published: (2019-11-01) -
hiPSC-Derived Cells as Models for Drug Discovery
by: Rivka Ofir
Published: (2021-08-01) -
hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery
by: Junjun Li, et al.
Published: (2020-11-01) -
Unprecedented Potential for Neural Drug Discovery Based on Self-Organizing hiPSC Platforms
by: Agustín Cota-Coronado, et al.
Published: (2020-03-01) -
Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies
by: Elena Abati, et al.
Published: (2021-09-01)